The Journal of Biomedical Research & Biotechnology (JBRB) is an international peer-reviewed journal dedicated to advancing scientific innovation and translational research in biomedical sciences, biotechnology, and healthcare technologies. The journal serves as a multidisciplinary platform for researchers, scientists, clinicians, biotechnologists, academicians, and healthcare professionals to publish original research and emerging discoveries that contribute to the improvement of human health and biomedical knowledge. JBRB encourages scientific collaboration and the integration of biological sciences with modern technological advancements to address current and future healthcare challenges. JBRB welcomes high-quality research articles focusing on molecular biology, genetic engineering, biomedical innovations, regenerative medicine, pharmaceutical biotechnology, clinical diagnostics, bioinformatics, and therapeutic development. The journal promotes interdisciplinary studies that bridge laboratory research with clinical and industrial applications, supporting the development of novel diagnostic tools, therapeutic strategies, vaccines, and biomedical devices. Through rigorous peer review and ethical publishing standards, the journal aims to support the global dissemination of reliable and impactful scientific research. The journal also encourages submissions related to artificial intelligence in healthcare, nanobiotechnology, stem cell research, personalized medicine, biomedical imaging, and computational biology. By fostering innovative scientific communication and translational research, JBRB aspires to become a trusted academic resource for advancing biomedical sciences and biotechnology worldwide. Keywords: Biomedical Research, Biotechnology, Molecular Biology, Genetic Engineering, Clinical Diagnostics, Biomedical Science, Regenerative Medicine, Pharmaceutical Biotechnology, Bioinformatics, Stem Cell Research, Nanobiotechnology, Personalized Medicine, Biomedical Imaging, Translational Medicine, Therapeutic Development, Healthcare Innovation, Artificial Intelligence in Healthcare, Computational Biology, Medical Biotechnology, Biomedical Engineering
Guidelines
We welcome high-quality, original research contributions that advance scientific knowledge and align with the scope of our peer-reviewed journals. To ensure a smooth submission and publication process, authors are requested to adhere to the following guidelines.
1. Manuscript Preparation
Formatting: Manuscripts should be submitted in MS Word format (.docx) using 12-point Times New Roman font, double-spaced, with 1-inch margins.
Structure:
Include the following sections as applicable: Title page, Abstract (250 words max), Keywords (3–5), Introduction, Materials and Methods, Results, Discussion, Conclusion, Acknowledgments, References.
Figures and Tables:
Numbered and captioned appropriately; include high-resolution images in separate files.
Reference Style:
Use APA Style, 7th Edition. Citations should be in-text (Author, Year) and listed in alphabetical order at the end.
Example (Journal Article):
Smith, J. A., & Brown, L. T. (2020). Climate trends in urban regions. Environmental Research Letters, 15(3), 123–134. https://doi.org/xx.xxx/yyyy
2. Submission Process
Manuscripts must be submitted via our online journal management system. Ensure all authors are listed and an ORCID iD is provided (optional but encouraged).
3. Peer Review
All submissions undergo a double-blind peer review process by subject experts. Authors can expect an initial decision within 1–2 weeks of submission.
4. Withdrawal Policy
Authors may withdraw their manuscript prior to peer review by notifying the editorial office via email. However, manuscripts withdrawn after peer review but before final decision may be subject to a withdrawal processing fee of USD $50. Withdrawal after acceptance is strongly discouraged and may result in a publication embargo for the authors.
5. Ethical Considerations
USOD Publishers follows COPE guidelines. Plagiarism, data fabrication, duplicate submissions, and unethical research practices are strictly prohibited.